ISRCTN29932893已完成不适用
Treatment strategy in patients with recurrent vasovagal syncope
Academic Medical Centre (AMC) (Netherlands)0 个研究点目标入组 300 人开始时间: 2005年12月20日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 300
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •1. Clinical diagnosis of classical neurally-mediated reflex syncope, based on the medical history or non-classical diagnosis of neurally-mediated reflex syncope and a positive tilt-table test
- •2. Three syncope episodes in the last year
- •3. Recognisable prodromal symptoms
- •4. Aged 18 - 70 years
排除标准
- •1. Suspected or certain heart disease and high likelihood of cardiac syncope
- •2. Orthostatic hypotension
- •3. Episodes of loss of consciousness different from syncope (e.g. epilepsy, psychiatric, metabolic, drop-attack, transient ischaemic attack [TIA], intoxication, cataplexy)
- •4. Steal syndrome
- •5. Psychologically or physically (due to any other illness) or cognitively unfit for participation in the study according to the opinion of the investigator
- •6. Patient compliance doubtful
- •7. Patient geographically or otherwise inaccessible for follow-up
- •8. Patient unwilling or unable to give informed consent
- •9. Pregnancy
- •10. Life expectancy less than 1 year
研究者
相似试验
招募中
不适用
Treatment strategy in patients with recurrent vasovagal syncope.Vasovagal syncopeNL-OMON28970Academic Medical Center300
招募中
2 期
Treatment of patients with relapsed or refractory CD19+ lymphoid disease with T lymphocytes transduced by RV-SFG.CD19.CD28.4-BBzeta retroviral vector – A unicenter Phase I/II clinical trial [HD-CAR-1]2024-516832-82-00Universitaetsklinikum Heidelberg AöR63
已完成
1 期
Clinical study on Prevention and treatment of Vascular dementia by invigorating spleen and Kidney, resolving phlegm and dredging collateralsVascular DemantiaITMCTR2100004618Shenzhen TCM Hospital
已完成
不适用
Establishment of optimal treatment for vascular endothelial dysfunction in patients with lifestyle-related diseaseslifestyle-related diseasesJPRN-UMIN000020720Department of Community Medicine for Diabetes and Metabolic Disorders, Institute of Biomedical Sciences, Tokushima University Graduate School500
进行中（未招募）
1 期
Management of moderate POstoperative recurrence in Crohn's disease: a randoMizEd contROLled trial, the POMEROL trial.Crohn's disease patients having an i2 endoscopic postoperative recurrence 6-12 months after ileocolonic anastomosis.EUCTR2021-002369-17-FRGETAID180